West Pharmaceutical Services (WST) FCF Margin (2009 - 2026)
West Pharmaceutical Services' (WST) quarterly FCF Margin came in at 9.26% in Q2 2026, down 403.0% year-over-year from 3.06% in Q2 2025, and up 65.81% quarter-over-quarter from 5.59% in Q1 2026.
Powered by 
Analysis
West Pharmaceutical Services (WST) FCF Margin (2009 - 2026) Analysis & Trends
West Pharmaceutical Services has disclosed FCF Margin across 18 years of filings, most recently posting 9.26% for Q2 2026.
- In Q2 2026, FCF Margin fell 403.0% year-over-year to 9.26%; the TTM figure through Jun 2026 stood at 13.13% (up 151.0% YoY), while the FY2025 annual figure was 15.25%, up 570.0% from the prior year.
- FCF Margin came in at 9.26% for Q2 2026 at West Pharmaceutical Services, up from 5.59% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 21.74% in Q4 2025 to a low of 3.97% in Q1 2024.
- Average FCF Margin over 5 years is 12.77%, with a median of 12.84% recorded in 2024.
- Year-over-year, FCF Margin tumbled 644 bps in 2024 and jumped 1036 bps in 2025.
- Over 5 years, FCF Margin stood at 19.18% in 2022, then decreased by 7 bps to 17.81% in 2023, then slumped by 36 bps to 11.38% in 2024, then jumped by 91 bps to 21.74% in 2025, then tumbled by 57 bps to 9.26% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 9.26% in Q2 2026, 5.59% in Q1 2026, and 21.74% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 12.70% |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 7.86% |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 9.26% |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 6.11% |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 29.65% |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 19.22% |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 8.41% |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | -24.47% |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | - |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.26% |
| Mar 31, 2026 | 5.59% |
| Dec 31, 2025 | 21.74% |
| Sep 30, 2025 | 16.64% |
| Jun 30, 2025 | 13.29% |
| Mar 31, 2025 | 8.32% |
| Dec 31, 2024 | 11.38% |
| Sep 30, 2024 | 13.23% |
| Jun 30, 2024 | 9.23% |
| Mar 31, 2024 | 3.97% |
| Dec 31, 2023 | 17.81% |
| Sep 30, 2023 | 17.97% |
| Jun 30, 2023 | 12.44% |
| Mar 31, 2023 | 7.81% |
| Dec 31, 2022 | 19.18% |
| Sep 30, 2022 | 16.17% |
| Jun 30, 2022 | 13.87% |
| Mar 31, 2022 | 11.86% |
| Dec 31, 2021 | 11.54% |
| Sep 30, 2021 | 17.66% |